|
|
||||||||
1
1 The Rolf Luft Center for Diabetes Research, Department of Molecular Medicine, Karolinska Institute, Karolinska Hospital, S-171 76 Stockholm, Sweden; and 2 Lomonosov Moscow State University, Moscow 19899, Russia
The objective of this study was to compare
effects of RX-871024, a compound with imidazoline structure, and the
sulfonylurea glibenclamide, representatives of two groups of
ATP-dependent potassium channel
(KATP) blockers, on insulin
secretion and cytoplasmic free calcium concentration
([Ca2+]i).
Furthermore, we studied the interaction of the compounds on these two
parameters. The experiments were performed in the perfused rat
pancreas, isolated rat pancreatic islets, and dispersed
-cells. At
maximal effective concentrations of the compounds, RX-871024 had a more
pronounced insulinotropic effect than glibenclamide, but the increase
in
[Ca2+]i
was similar. Glibenclamide enhanced the insulinotropic effect of
suboptimal concentrations of RX-871024 at 3.3 and 16.7 mM glucose. Notably, glibenclamide and RX-871024 also stimulated insulin secretion under Ca2+-clamped conditions,
i.e., during plasma membrane depolarization with KCl and glucose or in
permeabilized islets. The magnitudes of insulin stimulation under the
latter types of conditions were similar for both compounds. It is
concluded that RX-871024 and the sulfonylurea glibenclamide promote
insulin secretion by two mechanisms, namely closure of
KATP channels and a direct
stimulation of exocytosis. At a similar increase in
[Ca2+]i,
the maximal stimulatory effect of RX-871024 on insulin secretion was
stronger than that of glibenclamide, implying that RX-871024 also
affects insulin secretion by a signal transduction pathway that is not
activated by glibenclamide.
pancreatic islets; insulin secretion; cytoplasmic free Ca2+ concentration
This article has been cited by other articles:
![]() |
A. M. Efanov, I. B. Appelskog, S. M. Abdel-Halim, A. Khan, R. Branstrom, O. Larsson, C.-G. Ostenson, H.-J. Mest, P.-O. Berggren, S. Efendic, et al. Insulinotropic activity of the imidazoline derivative RX871024 in the diabetic GK rat Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E117 - E124. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L.F. Chan, M. Mourtada, and N. G. Morgan Characterization of a KATP Channel--Independent Pathway Involved in Potentiation of Insulin Secretion by Efaroxan Diabetes, February 1, 2001; 50(2): 340 - 347. [Abstract] [Full Text] |
||||
![]() |
J. An, G. Zhao, L. M. Churgay, J. J. Osborne, J. E. Hale, G. W. Becker, G. Gold, L. E. Stramm, and Y. Shi Threonine phosphorylations induced by RX-871024 and insulin secretagogues in beta TC6-F7 cells Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E862 - E869. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. MORGAN, S. L. F. CHAN, M. MOURTADA, L. K. MONKS, and C. A. RAMSDEN Imidazolines and Pancreatic Hormone Secretion Ann. N.Y. Acad. Sci., June 21, 1999; 881(1): 217 - 228. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |